Roles of intrinsic and acquired resistance determinants in multidrug-resistant clinical Pseudomonas aeruginosa in Bangladesh

被引:3
|
作者
Anjum, Hasnain [1 ]
Arefin, Md. Shamsul [1 ]
Jahan, Nusrat [2 ]
Oishee, Mumtarin Jannat [1 ]
Nahar, Shamsun [1 ]
Islam, Salequl [1 ]
Banerjee, Sudeshna [3 ]
Sinha, Susmita [4 ]
Kumar, Santosh [5 ]
Haque, Mainul [6 ,7 ]
Rahman, M. Hasibur [1 ]
机构
[1] Jahangirnagar Univ, Dept Microbiol, Dhaka 1342, Bangladesh
[2] Jahangirnagar Univ, Dept Biochem & Mol Biol, Dhaka 1342, Bangladesh
[3] Shri Anand Coll Nursing, Dept Med & Surg Nursing, Rajkot, Gujarat, India
[4] Khulna City Med Coll & Hosp, Dept Physiol, KDA Ave, Khulna, Bangladesh
[5] Karnavati Univ, Karnavati Sch Dent, Dept Periodontol, Gandhinagar, Gujarat, India
[6] Univ Pertahanan Nasl Malaysia, Natl Def Univ Malaysia, Fac Med & Defence Hlth, Kem Perdana Sungai Besi, Kuala Lumpur 57000, Malaysia
[7] Karnavati Univ, Karnavati Sch Dent, Dept Sci Res Ctr KSRC, Gandhinagar 382422, Gujarat, India
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2023年 / 22卷 / 03期
关键词
Pseudomonas aeruginosa; ESKAPE; OprD; Innate and Attained Resistance; Multidrug-resistant; Clinical Outcome; Bangladesh; SPECTRUM BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; ESKAPE PATHOGENS; DRUG-RESISTANCE; OUTER-MEMBRANE; SUSCEPTIBILITY PATTERN; RIBOSOMAL DNA; EFFLUX PUMPS;
D O I
10.3329/bjms.v22i3.66960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pseudomonas aeruginosa is an ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, P. aeruginosa, and Enterobacter spp.) pathogen and one of the leading etiologies in multiple nosocomial infections. Treatment of P. aeruginosa is becoming increasingly difficult due to its ever-increasing antibiotic resistance trends. This study investigated clinical multidrug resistance (MDR) P. aeruginosa (MDR-PA), their intrinsic resistance determinants, including the presence of chromosomal AmpC fl-lactamase (Ampicillinase), decreased expression of outer membrane porin protein OprD and selected acquired fl-lactamase resistance genes. Methods: Out of 238 clinical specimens, including urines from urinary tract-infected patients, wound swabs, burn swabs, and catheter aspirates, were collected from two major hospitals in Savar, Dhaka, Bangladesh. Samples were inoculated with Cetrimide agar to isolate presumptive P. aeruginosa. Bacteria were identified by cultural, biochemical characterization, 16S rDNA sequencing, and phylogenetic analysis. Virulence-associated genes of P. aeruginosa, namely, toxA, lasB, and plcH, were identified by polymerase chain reaction (PCR). Antibiotic susceptibilities of the isolates were investigated against ten antibiotics belonging to seven groups by disc-diffusion method followed by a selected minimum inhibitory concentration (MIC) assay. Phenotypic expression of Metallo-fl-lactamases (MBLs) production was checked by the double disc synergistic test selectively among the imipenem-resistant isolates. Acquisition of fl-lactam resistance trait was examined by PCR detection of bla-genes variants. Mutational loss of the OprD was analyzed by PCR to investigate intrinsic resistance determinants. Phenotypic overexpression of chromosomal AmpC was assayed with the identification of the AmpC gene by PCR. The expression level of OprD was assessed by real-time quantitative PCR (RT-qPCR). Results: Fifty-three P. aeruginosa was identified, with an overall isolation of 22.3% (53/238), where urine remains the most prevalent source. Virulence genes toxA, lasB, and plcH were identified in the isolates of 92.4%, 96.2%, and 94.3%. The highest phenotypic antimicrobial resistance was observed against ampicillin and ceftriaxone (100%), followed by cefotaxime (96%), tetracycline (89%), azithromycin (72%), imipenem (31%), ciprofloxacin (29%), levofloxacin (29%), gentamycin (27%) and ceftazidime (14%). The antibiogram pattern revealed 85% of isolates as multidrug-resistant, while 12% were considered extensively drug-resistant (XDR)-P. aeruginosa. The carriage of fl-lactamase genes blaTEM, blaSHV, and blaOXA was detected in 4%, 2%, and 2% cephalosporin-resistant isolates, respectively. Double disc synergistic test revealed 87% of imipenem-resistant isolates expressing MBL-mediated resistance phenomenon. All seven ceftazidime-resistant isolates showed the presence of the AmpC gene with phenotypic overproduction of the AmpC enzyme, indicating AmpC-mediated ceftazidime resistance. Mutational loss of OprD was observed in 12% of phenotypically multidrug-resistant isolates, and RT-qPCR analysis revealed reduced expression of OprD porin protein at various levels in the outer membrane of multidrug-resistant isolates. Conclusions: This study depicts the high prevalence of MDR-PA in clinical specimens in Bangladesh. The identified intrinsic and acquired antimicrobial resistance determinants play synergistic roles in emerging MDR-PA.
引用
收藏
页码:489 / 507
页数:19
相关论文
共 50 条
  • [31] Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7
    Morita, Yuji
    Tomida, Junko
    Kawamura, Yoshiaki
    MICROBIOLOGY-SGM, 2012, 158 : 1071 - 1083
  • [32] Integron-associated resistance genes among multidrug-resistant Pseudomonas aeruginosa isolated from clinical specimens
    Budak, Fatma
    Kasap, Murat
    Kolayli, Fetiye
    Karadenizli, Aynur
    Vahaboglu, Mustafa Haluk
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (01) : 149 - 156
  • [33] Salvage Therapy with CeftolozaneTazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
    Jose Caston, Juan
    De la Torre, Alvaro
    Ruiz-Camps, Isabel
    Luisa Sorli, Maria
    Torres, Vicente
    Torre-Cisneros, Julian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
  • [34] Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit
    Durojaiye, O. C.
    Carbarns, N.
    Murray, S.
    Majumdar, S.
    JOURNAL OF HOSPITAL INFECTION, 2011, 78 (02) : 154 - 155
  • [35] Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa
    Rizvi, Meher
    Ahmad, Junaid
    Khan, Fatima
    Shukla, Indu
    Malik, Abida
    Sami, Hiba
    AUSTRALASIAN MEDICAL JOURNAL, 2015, 8 (01): : 1 - 6
  • [36] Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa
    Maeda, Kumiko
    Kobayashi, Youko
    Oie, Shigeharu
    Ishida, Shiro
    Okano, Yoshiro
    Kobayashi, Toshihiko
    Shikichi, Kyoko
    Mizuno, Hidekazu
    Kamiya, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1898 - 1901
  • [37] Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa
    Giamarellos-Bourboulis, EJ
    Kentepozidis, N
    Antonopoulou, A
    Plachouras, D
    Tsaganos, T
    Giamarellou, H
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (02) : 113 - 117
  • [38] Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
    Hirsch, Elizabeth B.
    Tam, Vincent H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 441 - 451
  • [39] ABDOMINAL COLISTIN IRRIGATION FOR MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTION
    Amer, Marwa
    Alghunaim, Razan
    Almaghrabi, Reem
    CRITICAL CARE MEDICINE, 2020, 48
  • [40] Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections
    Pipitone, Giuseppe
    Di Bella, Stefano
    Maraolo, Alberto Enrico
    Granata, Guido
    Gatti, Milo
    Principe, Luigi
    Russo, Alessandro
    Gizzi, Andrea
    Pallone, Rita
    Cascio, Antonio
    Iaria, Chiara
    ANTIBIOTICS-BASEL, 2023, 12 (12):